| 000 | 01396 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515010337.0 | ||
| 264 | 0 | _c20060321 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/dki437 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJones, Ronald N | |
| 245 | 0 | 0 |
_aOxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cFeb 2006 |
||
| 300 |
_a279-87 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetamides _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Infections _xmicrobiology |
| 650 | 0 | 4 |
_aGram-Positive Bacteria _xdrug effects |
| 650 | 0 | 4 |
_aGram-Positive Cocci _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinezolid |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aOxazolidinones _xpharmacology |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 700 | 1 | _aRoss, James E | |
| 700 | 1 | _aFritsche, Thomas R | |
| 700 | 1 | _aSader, Helio S | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 57 _gno. 2 _gp. 279-87 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dki437 _zAvailable from publisher's website |
| 999 |
_c15948610 _d15948610 |
||